Matarin Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-229,215
| Closed | -$6.66M | – | 281 |
|
|
2018
Q4 | $6.66M | Sell |
229,215
-183,978
| -45% | -$5.35M | 0.54% | 73 |
|
|
2018
Q3 | $19M | Buy |
413,193
+32,588
| +9% | +$1.5M | 1.23% | 8 |
|
|
2018
Q2 | $14.2M | Sell |
380,605
-18,223
| -5% | -$681K | 1.03% | 19 |
|
|
2018
Q1 | $11.8M | Buy |
398,828
+14,575
| +4% | +$431K | 0.88% | 32 |
|
|
2017
Q4 | $13.2M | Buy |
384,253
+335,395
| +686% | +$11.5M | 1.03% | 17 |
|
|
2017
Q3 | $1.77M | Buy |
+48,858
| New | +$1.77M | 0.15% | 170 |
|
|
2013
Q4 | – | Sell |
-19,383
| Closed | -$456K | – | 148 |
|
|
2013
Q3 | $456K | Buy |
19,383
+2,502
| +15% | +$58.9K | 0.38% | 99 |
|
|
2013
Q2 | $454K | Buy |
+16,881
| New | +$454K | 0.46% | 91 |
|